The impact of a multi-disciplinary management approach on diabetic control in young Saudi patients

Annals of Saudi Medicine

Volumn 25, Issue 2, 2005, Pages 85-89

  Udezue, Emmanuel ^a   Nashwan, Rajaa ^a   Azim, Amal Abdel ^a   Hasweh, Munir ^a   Al Nuaim, Aydah ^a   Al Dossary, Ibrahim ^a  

^a SAUDI ARAMCO   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ARTICLE; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET THERAPY; DISEASE SEVERITY; EXERCISE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MICROANGIOPATHY; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA;

EID: 18744388904     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.85     Document Type: Article

References (26)

1. Fagot-Campagna A, Venkat Narayan KM. Type 2 diabetes in children. BMJ. 2001;322:377-378
2. Dokheel TM. An epidemic of childhood diabetes in the United States? Evidence from Allegheny County, Pennsylvania. Pittsburgh Diabetes Epidemiology Research Group. Diabetes Care,. 1993;16(12):1606-1611
3. Ehtisham S. Prevalence of type 2 diabetes in children in Birmingham. BMJ. 2001;322:1428
4. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22(2):345-354
5. An American epidemic. Newsweek 2000 September 4:40-46
6. Udezue, E. A five year experience of a short-stay observation unit in Saudi Arabia. Annals of Saudi Medicine 2003;23(1-2):72-75
7. Department of Health. National Service Framework (NSF) for Diabetes: Standards. London. UK 2001
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26:33-50
9. Canadian Medical Association. 1998 Clinical Practice Guidelines for the management of diabetes in Canada. CMAJ. 1998;159(8 Suppl):S1-S29.
10. Millar, WJ Stephens T. The prevalence of overweight and obesity in Britain, Canada, and United States. Amer J Pub Health. 1987;77(1):38-41
11. Alwan, King H. Diabetes in the Eastern Mediterranean (Middle East) Region. The World Health Organisation responds to a major public health challenge. Diabetic Medicine 1995;12:1057-58
12. Gill, G. Diabetes an increasing problem in the Middle East. International Diabetes Digest 1996:7(1):1
13. King H, Aubert R E, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998;1: 1414-1431.
14. Bagust A, Hopkinson P, Maslove I, et al. The projected health care burden of type 2 diabetes in the UK from 2000 to 2060. Diabetic Medicine 2002;19(suppl 4):1-5
15. O'Brien JA, Patrick AR, Caro JJ. Cost of managing complications resulting from type 2 diabetes in Canada. BMC Health Sciences Research 2003;3:7-12
16. Mayor, S. Government publishes strategy to improve diabetes care. BMJ. 2003;326(7381):121-123
17. Mudur G. Task force proposes changing body mass indicators for diabetes (India). BMJ. 2003;326(7381):126-7
18. Clark CM. How should we respond to the worldwide diabetes epidemic? Diabetes Care 1998;21:475-6
19. American Diabetic Association. Type 2 diabetes in children and adolescents (A Consensus statement) Diabetes Care 2000;1563-80
20. Zhang LiYing, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial Type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001;24:1275-1279
21. Saum SL, Thomas E, Martyn Lewis A, Croft PR. The effect of diabetic control on the incidence of, and changes in, retinopathy in type 2 non-insulin dependent diabetic patients. Brit Journ Gen Pract. 2002;52:212-21
22. Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter CD, Stehouwer CDA and Polak BCP. Risk factors for incident retinopathy in a diabetic and non-diabetic population: The Hoorn study. Arch Ophthalmol. 2003;121(2):245-251
23. Henricsson M, Nystrom L, Blohme G, Ostman J Kullberg C Svensson M et al. the incidence of retinopathy 10 years after diagnosis in young adult people with diabetes. Diabetes Care 2003;26:349-354
24. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329:977-986
25. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvasular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412
26. Kohner, E. Comment: treatment of diabetic retinopathy. BMJ. 2003;326(7397):1023-1025